– USA, CA – NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) today announced the appointments of Dr. Audrey Kunin (M.D.) and Julie Garlikov to its Board of Directors, effective immediately.
NovaBay also announces the resignation of Paul Li as a director. His vacancy is being filled by Sean Zheng. The Board has increased its size from six to eight members.
“This is an exciting, transformational time at NovaBay with the recent addition of DERMAdoctor and our planned further expansion into the large, lucrative OTC eyecare and skincare markets. We are delighted to welcome professionals to our Board who bring highly relevant experience and records of success,” said Board Chairman, Paul Freiman.
He added: “In less than two months Audrey has proven her leadership skills and industry knowledge, and is instrumental to our new product strategy and the development of innovative products for both the skincare and eyecare markets. We look forward to calling upon Julie’s expertise and fresh ideas, particularly in formulating effective digital and social media strategies to create brand awareness and demand generation for our products.”
“Sean has international experience in the medical device arena and was recommended to fill our Board vacancy by several of our large ex-US stockholders,” he added. “The Board would like to thank Paul for his valuable contributions over his nearly seven years of service as a director.”
About Dr. Audrey Kunin
Dr. Kunin is a recognized leader in the skincare product industry and has served as NovaBay’s Chief Product Officer since its acquisition in November 2021 of DERMAdoctor, LLC, a company she cofounded.
Dr. Kunin has been the creative force behind all DERMAdoctor products since 1998. At DERMAdoctor, she led the formulation and development of numerous innovative skin care products. Dr. Kunin graduated from Ohio State University and received her M.D. from the Medical College of Ohio. She completed postgraduate training in dermatology at the Medical College of Virginia after serving as Chief Resident. She is a fellow of the American Academy of Dermatology and formerly served as an Assistant Clinical Instructor of Dermatology at the University of Kansas School of Medicine.
About Julie Garlikov
Ms. Garlikov brings to NovaBay more than 25 years of marketing experience, including deep expertise in health, beauty, eye care, and dermatology products.
Ms. Garlikov is a classically trained consumer product goods marketer who gained her consumer experience at Procter & Gamble, Johnson & Johnson, and PepsiCo. Since 2020 she has served as VP of Marketing of GRAIL, LLC, a multi-cancer early detection company. Before GRAIL she was CMO at NewAge, Inc., a healthy products company where she led all aspects of global marketing including product development, creative, social media, digital, and branding. She previously was CMO of Shaklee Corporation and held senior marketing positions at dermatological skincare companies Rodan + Fields, Obagi Medical, and Nuvesse Skin Therapies. Ms. Garlikov holds a BA from the University of California, Berkeley, and an MBA from Columbia University.
About Sean Zheng
Mr. Zheng brings to NovaBay more than 27 years of experience in mergers and acquisitions, fund management, and the import/export business. He is CEO of Q3 Medical Devices (Shanghai) Co. Ltd., having previously held CEO and Managing Director positions at Boill Fund Management (HK) Co., Ltd. and Sprott-Zijin Mining Fund, a joint venture fund between Zijin Mining Group and Sprott Asset Management LP. Mr. Zheng is a chartered financial analyst and graduated from China’s Renmin University. He received an MBA from the University of New South Wales in 2002 and an MA of EMBA from China Europe International Business School in 2010.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova is the most prescribed antimicrobial lid and lash spray and CelleRx is a breakthrough product in the beauty category. In November 2021, NovaBay acquired DERMAdoctor, LLC, a company offering more than 30 dermatologist-developed skin care products sold through traditional domestic retailers, digital beauty channels, and international distributors.
For more information: https://novabay.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
